paclitaxel has been researched along with Mesenteric Vascular Occlusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briguori, C; Taranto, D; Visconti, G | 1 |
| Cardaioli, P; Giordan, M; Rigatelli, G; Zattoni, L | 1 |
| Feenstra, J; Stricker, BH; Vermeer, RJ | 1 |
3 other study(ies) available for paclitaxel and Mesenteric Vascular Occlusion
| Article | Year |
|---|---|
Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Celiac Artery; Chronic Disease; Constriction, Pathologic; Drug-Eluting Stents; Female; Humans; Ischemia; Magnetic Resonance Angiography; Mesenteric Vascular Occlusion; Metals; Paclitaxel; Prosthesis Design; Recurrence; Stents; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Drug-eluting stent for recurrent mesenteric artery in-stent restenosis.
Topics: Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Cardiovascular Agents; Drug-Eluting Stents; Female; Humans; Mesenteric Artery, Superior; Mesenteric Vascular Occlusion; Paclitaxel; Platelet Aggregation Inhibitors; Secondary Prevention; Stents; Tomography, X-Ray Computed; Treatment Outcome; Vascular Patency | 2007 |
Mesenteric venous thrombosis attributed to docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Docetaxel; Female; Humans; Lung Neoplasms; Mesenteric Vascular Occlusion; Mesenteric Veins; Middle Aged; Osteolysis; Paclitaxel; Sternum; Taxoids; Venous Thrombosis | 2000 |